(Q54317902)
Statements
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors. (English)
1 reference
1 reference
1 reference
L Rhoda Molife
1 reference
Montserrat Blanco-Codesido
1 reference
Andre T Brunetto
1 reference
Lucy Lee
1 reference
Galina Kuznetsov
1 reference
Khin Than Myint
1 reference
Karen Wood
1 reference
Begoña de Las Heras
1 reference
Malcolm Richard Ranson
1 reference
2 October 2014
1 reference
20
1 reference
6284-6294
1 reference
24
1 reference
Identifiers
1 reference